UCLA Health

You are here

Location Info

UCLA Health
Hematopoeitic Malignancy/Stem Cell Transplant & Cellular Therapies Program
757 Westwood Plaza,
Los Angeles, CA 90095
Phone number: (310) 206-6909

Background data

Program type: Adult Program
FACT Approved: Yes
Year CAR T-cell Therapy Program Opened: 2018

CAR T-cell therapies performed

Year 2020 2021 2022 2023
Number Performed - - 40 46

Program Director

Name Phone
Emi Kamiya, MBA (310) 206-6909

Medical Director

Name Phone
Gary Schiller, MD (310) 825-5513

Physician

Name Phone
Sven de Vos, MD, PhD (310) 206-6909
Herbert Eradat, MD (310) 206-6909
Sarah Larson, MD (310) 206-6909
Monica Mead, MD (310) 206-6909
Levanto Schachter, DO
Gary Schiller, MD (310) 825-5513
Christopher Seet, MD, PhD (310) 206-6909
John Timmerman, MD (310) 206-6909
Patricia Young, MD (310) 206-6909

Coordinator

Name Phone
Cellular Therapy Coordinator Manager, (310) 267-7198

Social Worker

Name Phone
Carolyn Bell, LCSW (310) 267-9702
Jacqueline Dillon, LCSW, OSC-C (310) 267-9702
Rebecca Pittenger, MSW, LCSW (310) 267-9702
Ariela Wenger, LCSW (310) 267-9702

Diseases treated by CAR T-cell therapy

  • Leukemia, acute lymphoblastic
  • Lymphoma
  • Mantle Cell Lymphoma
  • Multiple Myeloma

CAR T-Cell products

  • Abecma (idecabtagene vicleucil, ide-cel)
  • Breyanzi (lisocabtagene maraleucel, liso-cel)
  • Carvykti (ciltacabtagene autoleucel, cita-cel)
  • Kymriah (tisagenlecleucel, tisa-cel)
  • Tecartus (brexucabtagene autoleucel, brexu-cel)
  • Yescarta (axicabtagene ciloleucel, axi-cel)